NephroDI Therapeutics, Inc.
Lack of concentration is our focus
Seattle, United States · Founded 2020
- Headquarters
- Seattle, Washington
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- nephrodi.com
About
NephroDI Therapeutics is a clinical-stage biopharmaceutical company developing novel AMPK activator therapies for kidney concentration disorders. Their lead program, NDI-5001, targets Congenital Nephrogenic Diabetes Insipidus (NDI), a rare pediatric orphan disease causing severe dehydration. The company has received NIH grant support and closed a Series A investment from Sound Bioventures in 2024.
Summary
NephroDI Therapeutics, Inc. is a Biotech company based in Seattle, United States, founded in 2020.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nephrodi-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/nephrodi-therapeutics-inc" alt="NephroDI Therapeutics, Inc. on Indexed.vc" width="260" height="76" /></a>